31 computational-solid-mechanics Postdoctoral positions at University of Maryland, Baltimore
Sort by
Refine Your Search
-
hypothesis that editing of MP lowers blood pressure in models of hypertension and heart failure, and will determine the mechanism(s) by which it does so. The post-doc will perform experiments in animal models
-
mechanisms of lung transplant tolerance. It was the first laboratory to describe the mouse model of orthotopic vascularized lung transplantation and has made seminal discoveries contributing to unique
-
research background in molecular and cellular biology. Research in our lab focuses on epigenetic and genetic mechanisms of pathologic conditions that occurred during liver and kidney transplantation by using
-
, epigenetics, biochemistry, cell biology, developmental biology, and bioinformatics to study the molecular mechanism of disease, identify / validate disease causing genetic variants, and test potential
-
on epigenetic and genetic mechanisms of pathologic conditions that occur during liver and kidney transplantation by using state-of-the-art technologies such as single cell genomics. This opportunity provides
-
molecular and cellular evaluations of conditions affecting long-term graft outcomes in solid organ transplant recipients. Overall, we apply systems biology approaches toward implementation of precision
-
project is to investigating possible mechanism underlying lung tumorigenesis and develop potential biomarker for the early detection of lung cancer. The “to be hired post-doc fellow” will participate in
-
hypothesis that editing of MP lowers blood pressure in models of hypertension and heart failure, and will determine the mechanism(s) by which it does so. The post-doc will perform experiments in animal models
-
cardiac remodeling following myocardial injury. An ambitious and creative Ph.D. or M.D. scientist is sought to determine the mechanism of their action. Qualifications Applicants are required to have a Ph.D
-
cells (hiPSCs). The Hong laboratory has identified small molecules that enhance cardiac performance in human IPSC-derived cardiomyocytes (iPSC-CMs). The first goal is to examine the mechanism of action